nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisplatin—SOD1—amyotrophic lateral sclerosis	0.332	0.565	CbGaD
Cisplatin—ABCG2—Riluzole—amyotrophic lateral sclerosis	0.212	1	CbGbCtD
Cisplatin—GSTP1—amyotrophic lateral sclerosis	0.194	0.33	CbGaD
Cisplatin—PTGS2—amyotrophic lateral sclerosis	0.0614	0.105	CbGaD
Cisplatin—Tetany—Riluzole—amyotrophic lateral sclerosis	0.00445	0.0666	CcSEcCtD
Cisplatin—BCHE—diaphragm—amyotrophic lateral sclerosis	0.00349	0.0865	CbGeAlD
Cisplatin—Generalised oedema—Riluzole—amyotrophic lateral sclerosis	0.00244	0.0365	CcSEcCtD
Cisplatin—Abscess—Riluzole—amyotrophic lateral sclerosis	0.00183	0.0274	CcSEcCtD
Cisplatin—Ageusia—Riluzole—amyotrophic lateral sclerosis	0.00179	0.0268	CcSEcCtD
Cisplatin—Liver injury—Riluzole—amyotrophic lateral sclerosis	0.00172	0.0258	CcSEcCtD
Cisplatin—Cellulitis—Riluzole—amyotrophic lateral sclerosis	0.0016	0.0239	CcSEcCtD
Cisplatin—Ulcer—Riluzole—amyotrophic lateral sclerosis	0.00153	0.023	CcSEcCtD
Cisplatin—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.00153	0.023	CcSEcCtD
Cisplatin—Hiccups—Riluzole—amyotrophic lateral sclerosis	0.00145	0.0217	CcSEcCtD
Cisplatin—Hepatocellular injury—Riluzole—amyotrophic lateral sclerosis	0.00145	0.0217	CcSEcCtD
Cisplatin—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.00138	0.0206	CcSEcCtD
Cisplatin—Phlebitis—Riluzole—amyotrophic lateral sclerosis	0.00122	0.0183	CcSEcCtD
Cisplatin—Deafness—Riluzole—amyotrophic lateral sclerosis	0.00118	0.0176	CcSEcCtD
Cisplatin—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.00116	0.0174	CcSEcCtD
Cisplatin—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.00112	0.0168	CcSEcCtD
Cisplatin—PTGS2—hindlimb—amyotrophic lateral sclerosis	0.0011	0.0273	CbGeAlD
Cisplatin—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00109	0.0163	CcSEcCtD
Cisplatin—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.00106	0.0158	CcSEcCtD
Cisplatin—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00105	0.0158	CcSEcCtD
Cisplatin—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.00102	0.0152	CcSEcCtD
Cisplatin—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.000979	0.0147	CcSEcCtD
Cisplatin—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.000962	0.0144	CcSEcCtD
Cisplatin—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.000958	0.0143	CcSEcCtD
Cisplatin—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.000952	0.0142	CcSEcCtD
Cisplatin—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.000948	0.0142	CcSEcCtD
Cisplatin—PTGS2—appendage—amyotrophic lateral sclerosis	0.000947	0.0235	CbGeAlD
Cisplatin—SLC31A2—medulla oblongata—amyotrophic lateral sclerosis	0.000937	0.0232	CbGeAlD
Cisplatin—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.000892	0.0134	CcSEcCtD
Cisplatin—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000873	0.0131	CcSEcCtD
Cisplatin—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.000864	0.0129	CcSEcCtD
Cisplatin—MT2A—spinal cord—amyotrophic lateral sclerosis	0.00085	0.0211	CbGeAlD
Cisplatin—SLC31A2—spinal cord—amyotrophic lateral sclerosis	0.000836	0.0207	CbGeAlD
Cisplatin—ATP7A—medulla oblongata—amyotrophic lateral sclerosis	0.000826	0.0205	CbGeAlD
Cisplatin—MT1A—cerebellum—amyotrophic lateral sclerosis	0.00081	0.0201	CbGeAlD
Cisplatin—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.0008	0.012	CcSEcCtD
Cisplatin—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.000796	0.0119	CcSEcCtD
Cisplatin—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.000796	0.0119	CcSEcCtD
Cisplatin—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.000791	0.0118	CcSEcCtD
Cisplatin—ATP7B—nervous system—amyotrophic lateral sclerosis	0.000771	0.0191	CbGeAlD
Cisplatin—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.000768	0.0115	CcSEcCtD
Cisplatin—ATP7B—central nervous system—amyotrophic lateral sclerosis	0.000742	0.0184	CbGeAlD
Cisplatin—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.000742	0.0111	CcSEcCtD
Cisplatin—ATP7A—spinal cord—amyotrophic lateral sclerosis	0.000736	0.0182	CbGeAlD
Cisplatin—ATP7B—cerebellum—amyotrophic lateral sclerosis	0.000725	0.018	CbGeAlD
Cisplatin—SOD1—medulla oblongata—amyotrophic lateral sclerosis	0.000723	0.0179	CbGeAlD
Cisplatin—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00072	0.0108	CcSEcCtD
Cisplatin—MT2A—nervous system—amyotrophic lateral sclerosis	0.000717	0.0178	CbGeAlD
Cisplatin—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.000716	0.0107	CcSEcCtD
Cisplatin—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.000714	0.0107	CcSEcCtD
Cisplatin—SLC31A1—medulla oblongata—amyotrophic lateral sclerosis	0.000704	0.0175	CbGeAlD
Cisplatin—SLC31A2—nervous system—amyotrophic lateral sclerosis	0.000704	0.0175	CbGeAlD
Cisplatin—GSTT1—nervous system—amyotrophic lateral sclerosis	0.000701	0.0174	CbGeAlD
Cisplatin—MT2A—central nervous system—amyotrophic lateral sclerosis	0.00069	0.0171	CbGeAlD
Cisplatin—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.000681	0.0102	CcSEcCtD
Cisplatin—SLC31A2—central nervous system—amyotrophic lateral sclerosis	0.000678	0.0168	CbGeAlD
Cisplatin—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.000676	0.0101	CcSEcCtD
Cisplatin—GSTP1—embryo—amyotrophic lateral sclerosis	0.000674	0.0167	CbGeAlD
Cisplatin—SLC31A2—cerebellum—amyotrophic lateral sclerosis	0.000663	0.0164	CbGeAlD
Cisplatin—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.000658	0.00985	CcSEcCtD
Cisplatin—MT1A—brain—amyotrophic lateral sclerosis	0.000658	0.0163	CbGeAlD
Cisplatin—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000657	0.00983	CcSEcCtD
Cisplatin—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.000651	0.00974	CcSEcCtD
Cisplatin—SOD1—spinal cord—amyotrophic lateral sclerosis	0.000645	0.016	CbGeAlD
Cisplatin—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.000644	0.00964	CcSEcCtD
Cisplatin—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.000634	0.00949	CcSEcCtD
Cisplatin—SLC31A1—spinal cord—amyotrophic lateral sclerosis	0.000628	0.0156	CbGeAlD
Cisplatin—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.000625	0.00935	CcSEcCtD
Cisplatin—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00061	0.00913	CcSEcCtD
Cisplatin—Tremor—Riluzole—amyotrophic lateral sclerosis	0.000594	0.00889	CcSEcCtD
Cisplatin—ATP7B—brain—amyotrophic lateral sclerosis	0.000589	0.0146	CbGeAlD
Cisplatin—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.000588	0.00881	CcSEcCtD
Cisplatin—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.000586	0.00877	CcSEcCtD
Cisplatin—Malaise—Riluzole—amyotrophic lateral sclerosis	0.000572	0.00856	CcSEcCtD
Cisplatin—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.000568	0.0085	CcSEcCtD
Cisplatin—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00055	0.00822	CcSEcCtD
Cisplatin—MT2A—brain—amyotrophic lateral sclerosis	0.000548	0.0136	CbGeAlD
Cisplatin—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00054	0.00808	CcSEcCtD
Cisplatin—SLC31A2—brain—amyotrophic lateral sclerosis	0.000538	0.0133	CbGeAlD
Cisplatin—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.000538	0.00805	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.000536	0.00803	CcSEcCtD
Cisplatin—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.000533	0.00798	CcSEcCtD
Cisplatin—SLC31A1—nervous system—amyotrophic lateral sclerosis	0.000529	0.0131	CbGeAlD
Cisplatin—Oedema—Riluzole—amyotrophic lateral sclerosis	0.000518	0.00775	CcSEcCtD
Cisplatin—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.000518	0.00775	CcSEcCtD
Cisplatin—GSTM1—nervous system—amyotrophic lateral sclerosis	0.000517	0.0128	CbGeAlD
Cisplatin—ABCC5—medulla oblongata—amyotrophic lateral sclerosis	0.000515	0.0128	CbGeAlD
Cisplatin—Infection—Riluzole—amyotrophic lateral sclerosis	0.000514	0.0077	CcSEcCtD
Cisplatin—SOD1—cerebellum—amyotrophic lateral sclerosis	0.000511	0.0127	CbGeAlD
Cisplatin—SLC31A1—central nervous system—amyotrophic lateral sclerosis	0.00051	0.0126	CbGeAlD
Cisplatin—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.000508	0.0076	CcSEcCtD
Cisplatin—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.000507	0.00759	CcSEcCtD
Cisplatin—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.000505	0.00756	CcSEcCtD
Cisplatin—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.000503	0.00753	CcSEcCtD
Cisplatin—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.0005	0.00749	CcSEcCtD
Cisplatin—SLC31A1—cerebellum—amyotrophic lateral sclerosis	0.000498	0.0123	CbGeAlD
Cisplatin—GSTM1—central nervous system—amyotrophic lateral sclerosis	0.000497	0.0123	CbGeAlD
Cisplatin—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.000493	0.00738	CcSEcCtD
Cisplatin—GSTM1—cerebellum—amyotrophic lateral sclerosis	0.000486	0.012	CbGeAlD
Cisplatin—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.000484	0.00724	CcSEcCtD
Cisplatin—NQO1—medulla oblongata—amyotrophic lateral sclerosis	0.000482	0.0119	CbGeAlD
Cisplatin—ATP7A—brain—amyotrophic lateral sclerosis	0.000474	0.0118	CbGeAlD
Cisplatin—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000472	0.00706	CcSEcCtD
Cisplatin—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000465	0.00696	CcSEcCtD
Cisplatin—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000461	0.00691	CcSEcCtD
Cisplatin—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00045	0.00673	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000447	0.00669	CcSEcCtD
Cisplatin—Pain—Riluzole—amyotrophic lateral sclerosis	0.000443	0.00663	CcSEcCtD
Cisplatin—GSTP1—medulla oblongata—amyotrophic lateral sclerosis	0.000431	0.0107	CbGeAlD
Cisplatin—NQO1—spinal cord—amyotrophic lateral sclerosis	0.00043	0.0106	CbGeAlD
Cisplatin—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000427	0.00638	CcSEcCtD
Cisplatin—SOD1—brain—amyotrophic lateral sclerosis	0.000415	0.0103	CbGeAlD
Cisplatin—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000409	0.00612	CcSEcCtD
Cisplatin—SLC31A1—brain—amyotrophic lateral sclerosis	0.000405	0.01	CbGeAlD
Cisplatin—MPO—spinal cord—amyotrophic lateral sclerosis	0.000395	0.00979	CbGeAlD
Cisplatin—GSTM1—brain—amyotrophic lateral sclerosis	0.000395	0.00978	CbGeAlD
Cisplatin—GSTP1—spinal cord—amyotrophic lateral sclerosis	0.000384	0.00952	CbGeAlD
Cisplatin—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000381	0.00571	CcSEcCtD
Cisplatin—BCHE—brainstem—amyotrophic lateral sclerosis	0.000374	0.00927	CbGeAlD
Cisplatin—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000371	0.00556	CcSEcCtD
Cisplatin—ABCC5—cerebellum—amyotrophic lateral sclerosis	0.000364	0.00902	CbGeAlD
Cisplatin—NQO1—nervous system—amyotrophic lateral sclerosis	0.000362	0.00897	CbGeAlD
Cisplatin—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000354	0.0053	CcSEcCtD
Cisplatin—NQO1—central nervous system—amyotrophic lateral sclerosis	0.000349	0.00864	CbGeAlD
Cisplatin—NQO1—cerebellum—amyotrophic lateral sclerosis	0.000341	0.00844	CbGeAlD
Cisplatin—MPO—nervous system—amyotrophic lateral sclerosis	0.000333	0.00825	CbGeAlD
Cisplatin—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000329	0.00493	CcSEcCtD
Cisplatin—Rash—Riluzole—amyotrophic lateral sclerosis	0.000326	0.00488	CcSEcCtD
Cisplatin—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000326	0.00488	CcSEcCtD
Cisplatin—ABCC3—nervous system—amyotrophic lateral sclerosis	0.000325	0.00805	CbGeAlD
Cisplatin—GSTP1—nervous system—amyotrophic lateral sclerosis	0.000324	0.00802	CbGeAlD
Cisplatin—MPO—central nervous system—amyotrophic lateral sclerosis	0.00032	0.00794	CbGeAlD
Cisplatin—PTGS2—embryo—amyotrophic lateral sclerosis	0.000314	0.00779	CbGeAlD
Cisplatin—ABCC3—central nervous system—amyotrophic lateral sclerosis	0.000313	0.00775	CbGeAlD
Cisplatin—GSTP1—central nervous system—amyotrophic lateral sclerosis	0.000312	0.00772	CbGeAlD
Cisplatin—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000307	0.0046	CcSEcCtD
Cisplatin—GSTP1—cerebellum—amyotrophic lateral sclerosis	0.000304	0.00754	CbGeAlD
Cisplatin—ABCC5—brain—amyotrophic lateral sclerosis	0.000296	0.00733	CbGeAlD
Cisplatin—NQO1—brain—amyotrophic lateral sclerosis	0.000277	0.00686	CbGeAlD
Cisplatin—BCHE—medulla oblongata—amyotrophic lateral sclerosis	0.000261	0.00646	CbGeAlD
Cisplatin—MPO—brain—amyotrophic lateral sclerosis	0.000254	0.0063	CbGeAlD
Cisplatin—ABCG2—medulla oblongata—amyotrophic lateral sclerosis	0.000252	0.00624	CbGeAlD
Cisplatin—ABCC3—brain—amyotrophic lateral sclerosis	0.000248	0.00615	CbGeAlD
Cisplatin—GSTP1—brain—amyotrophic lateral sclerosis	0.000247	0.00613	CbGeAlD
Cisplatin—BCHE—spinal cord—amyotrophic lateral sclerosis	0.000232	0.00576	CbGeAlD
Cisplatin—ABCG2—spinal cord—amyotrophic lateral sclerosis	0.000225	0.00557	CbGeAlD
Cisplatin—PTGS2—medulla oblongata—amyotrophic lateral sclerosis	0.000201	0.00498	CbGeAlD
Cisplatin—BCHE—nervous system—amyotrophic lateral sclerosis	0.000196	0.00485	CbGeAlD
Cisplatin—ABCB1—embryo—amyotrophic lateral sclerosis	0.000194	0.00482	CbGeAlD
Cisplatin—BCHE—central nervous system—amyotrophic lateral sclerosis	0.000189	0.00467	CbGeAlD
Cisplatin—BCHE—cerebellum—amyotrophic lateral sclerosis	0.000184	0.00457	CbGeAlD
Cisplatin—PTGS2—spinal cord—amyotrophic lateral sclerosis	0.000179	0.00444	CbGeAlD
Cisplatin—ABCG2—cerebellum—amyotrophic lateral sclerosis	0.000178	0.00442	CbGeAlD
Cisplatin—CYP2B6—nervous system—amyotrophic lateral sclerosis	0.000175	0.00433	CbGeAlD
Cisplatin—CYP2B6—central nervous system—amyotrophic lateral sclerosis	0.000168	0.00417	CbGeAlD
Cisplatin—PTGS2—nervous system—amyotrophic lateral sclerosis	0.000151	0.00374	CbGeAlD
Cisplatin—BCHE—brain—amyotrophic lateral sclerosis	0.00015	0.00371	CbGeAlD
Cisplatin—PTGS2—central nervous system—amyotrophic lateral sclerosis	0.000145	0.0036	CbGeAlD
Cisplatin—ABCG2—brain—amyotrophic lateral sclerosis	0.000145	0.00359	CbGeAlD
Cisplatin—PTGS2—cerebellum—amyotrophic lateral sclerosis	0.000142	0.00352	CbGeAlD
Cisplatin—CYP2B6—brain—amyotrophic lateral sclerosis	0.000134	0.00331	CbGeAlD
Cisplatin—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.000124	0.00308	CbGeAlD
Cisplatin—PTGS2—brain—amyotrophic lateral sclerosis	0.000115	0.00286	CbGeAlD
Cisplatin—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.000111	0.00275	CbGeAlD
Cisplatin—ABCB1—nervous system—amyotrophic lateral sclerosis	9.34e-05	0.00231	CbGeAlD
Cisplatin—ABCB1—central nervous system—amyotrophic lateral sclerosis	8.99e-05	0.00223	CbGeAlD
Cisplatin—ABCB1—cerebellum—amyotrophic lateral sclerosis	8.79e-05	0.00218	CbGeAlD
Cisplatin—ABCB1—brain—amyotrophic lateral sclerosis	7.14e-05	0.00177	CbGeAlD
Cisplatin—ABCC3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	4.39e-05	0.000473	CbGpPWpGaD
Cisplatin—ATP7A—Cellular responses to stress—TP53—amyotrophic lateral sclerosis	4.36e-05	0.00047	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—PLB1—amyotrophic lateral sclerosis	4.28e-05	0.000461	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—DAO—amyotrophic lateral sclerosis	4.22e-05	0.000454	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.22e-05	0.000454	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—CD40LG—amyotrophic lateral sclerosis	4.13e-05	0.000444	CbGpPWpGaD
Cisplatin—ABCC2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	4.1e-05	0.000441	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—GSR—amyotrophic lateral sclerosis	4.06e-05	0.000437	CbGpPWpGaD
Cisplatin—MT2A—Immune System—ERBB4—amyotrophic lateral sclerosis	4.05e-05	0.000436	CbGpPWpGaD
Cisplatin—SOD1—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	4.01e-05	0.000431	CbGpPWpGaD
Cisplatin—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	3.99e-05	0.000429	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—FIG4—amyotrophic lateral sclerosis	3.96e-05	0.000427	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—GSR—amyotrophic lateral sclerosis	3.95e-05	0.000426	CbGpPWpGaD
Cisplatin—ABCC5—Disease—VCP—amyotrophic lateral sclerosis	3.92e-05	0.000422	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—CHAT—amyotrophic lateral sclerosis	3.92e-05	0.000422	CbGpPWpGaD
Cisplatin—ABCC3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	3.92e-05	0.000422	CbGpPWpGaD
Cisplatin—ABCG2—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	3.92e-05	0.000422	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	3.88e-05	0.000417	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	3.86e-05	0.000415	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PLB1—amyotrophic lateral sclerosis	3.84e-05	0.000414	CbGpPWpGaD
Cisplatin—MT2A—Immune System—CD40LG—amyotrophic lateral sclerosis	3.81e-05	0.00041	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—TPK1—amyotrophic lateral sclerosis	3.79e-05	0.000408	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—VAPB—amyotrophic lateral sclerosis	3.79e-05	0.000408	CbGpPWpGaD
Cisplatin—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—amyotrophic lateral sclerosis	3.75e-05	0.000404	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PLB1—amyotrophic lateral sclerosis	3.68e-05	0.000397	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—C3—amyotrophic lateral sclerosis	3.65e-05	0.000393	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	3.59e-05	0.000386	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—DAO—amyotrophic lateral sclerosis	3.58e-05	0.000386	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	3.57e-05	0.000385	CbGpPWpGaD
Cisplatin—ABCG2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	3.56e-05	0.000384	CbGpPWpGaD
Cisplatin—XDH—Metabolism—GSR—amyotrophic lateral sclerosis	3.55e-05	0.000382	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	3.55e-05	0.000382	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	3.53e-05	0.00038	CbGpPWpGaD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	3.53e-05	0.00038	CbGpPWpGaD
Cisplatin—ABCC2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	3.48e-05	0.000375	CbGpPWpGaD
Cisplatin—ABCC2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	3.48e-05	0.000375	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	3.48e-05	0.000375	CbGpPWpGaD
Cisplatin—SOD1—Cellular responses to stress—VEGFA—amyotrophic lateral sclerosis	3.48e-05	0.000374	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—VAPA—amyotrophic lateral sclerosis	3.46e-05	0.000373	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—VAPB—amyotrophic lateral sclerosis	3.42e-05	0.000368	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—TPK1—amyotrophic lateral sclerosis	3.42e-05	0.000368	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—GSR—amyotrophic lateral sclerosis	3.4e-05	0.000366	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—TPK1—amyotrophic lateral sclerosis	3.38e-05	0.000364	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—VAPB—amyotrophic lateral sclerosis	3.38e-05	0.000364	CbGpPWpGaD
Cisplatin—MT2A—Immune System—C3—amyotrophic lateral sclerosis	3.37e-05	0.000362	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—CHAT—amyotrophic lateral sclerosis	3.33e-05	0.000359	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	3.3e-05	0.000355	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	3.28e-05	0.000353	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	3.28e-05	0.000353	CbGpPWpGaD
Cisplatin—CYP2B6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.27e-05	0.000352	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.27e-05	0.000352	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—CHAT—amyotrophic lateral sclerosis	3.25e-05	0.000349	CbGpPWpGaD
Cisplatin—CYP2B6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.22e-05	0.000347	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.22e-05	0.000347	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	3.21e-05	0.000345	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PLB1—amyotrophic lateral sclerosis	3.19e-05	0.000344	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—IGF1—amyotrophic lateral sclerosis	3.16e-05	0.00034	CbGpPWpGaD
Cisplatin—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	3.14e-05	0.000338	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—VAPA—amyotrophic lateral sclerosis	3.13e-05	0.000336	CbGpPWpGaD
Cisplatin—PTGS2—Disease—TPK1—amyotrophic lateral sclerosis	3.11e-05	0.000335	CbGpPWpGaD
Cisplatin—ABCC2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	3.11e-05	0.000334	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	3.1e-05	0.000334	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—VAPA—amyotrophic lateral sclerosis	3.09e-05	0.000333	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—VEGFA—amyotrophic lateral sclerosis	3.03e-05	0.000326	CbGpPWpGaD
Cisplatin—ABCG2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	3.03e-05	0.000326	CbGpPWpGaD
Cisplatin—ABCG2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	3.03e-05	0.000326	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—FIG4—amyotrophic lateral sclerosis	3.03e-05	0.000326	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	3.01e-05	0.000324	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3e-05	0.000323	CbGpPWpGaD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	3e-05	0.000323	CbGpPWpGaD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	3e-05	0.000323	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	2.99e-05	0.000322	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—GSR—amyotrophic lateral sclerosis	2.95e-05	0.000317	CbGpPWpGaD
Cisplatin—XDH—Metabolism—CHAT—amyotrophic lateral sclerosis	2.91e-05	0.000313	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.91e-05	0.000313	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.88e-05	0.00031	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	2.87e-05	0.000309	CbGpPWpGaD
Cisplatin—ABCC5—Disease—CST3—amyotrophic lateral sclerosis	2.81e-05	0.000303	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—CHAT—amyotrophic lateral sclerosis	2.79e-05	0.000301	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—DAO—amyotrophic lateral sclerosis	2.74e-05	0.000295	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—FIG4—amyotrophic lateral sclerosis	2.73e-05	0.000294	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PLB1—amyotrophic lateral sclerosis	2.72e-05	0.000292	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—FIG4—amyotrophic lateral sclerosis	2.7e-05	0.000291	CbGpPWpGaD
Cisplatin—ABCG2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	2.7e-05	0.000291	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.68e-05	0.000289	CbGpPWpGaD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	2.67e-05	0.000288	CbGpPWpGaD
Cisplatin—SOD1—Cellular responses to stress—TP53—amyotrophic lateral sclerosis	2.63e-05	0.000283	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—TPK1—amyotrophic lateral sclerosis	2.61e-05	0.000281	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—VAPB—amyotrophic lateral sclerosis	2.61e-05	0.000281	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	2.53e-05	0.000273	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—GSR—amyotrophic lateral sclerosis	2.51e-05	0.00027	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—TPK1—amyotrophic lateral sclerosis	2.51e-05	0.00027	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—VAPB—amyotrophic lateral sclerosis	2.51e-05	0.00027	CbGpPWpGaD
Cisplatin—PTGS2—Disease—VTA1—amyotrophic lateral sclerosis	2.49e-05	0.000268	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—APOE—amyotrophic lateral sclerosis	2.47e-05	0.000266	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—DAO—amyotrophic lateral sclerosis	2.47e-05	0.000266	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—DAO—amyotrophic lateral sclerosis	2.45e-05	0.000263	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.43e-05	0.000262	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	2.42e-05	0.000261	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—CHAT—amyotrophic lateral sclerosis	2.42e-05	0.000261	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—VAPA—amyotrophic lateral sclerosis	2.38e-05	0.000257	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—TP53—amyotrophic lateral sclerosis	2.29e-05	0.000247	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—VAPA—amyotrophic lateral sclerosis	2.29e-05	0.000247	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.28e-05	0.000246	CbGpPWpGaD
Cisplatin—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.25e-05	0.000242	CbGpPWpGaD
Cisplatin—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.22e-05	0.000239	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.22e-05	0.000239	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—CASP3—amyotrophic lateral sclerosis	2.21e-05	0.000238	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.21e-05	0.000238	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	2.16e-05	0.000233	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	2.13e-05	0.00023	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.13e-05	0.000229	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.12e-05	0.000229	CbGpPWpGaD
Cisplatin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	2.12e-05	0.000228	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.11e-05	0.000227	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—MMP9—amyotrophic lateral sclerosis	2.09e-05	0.000225	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—FIG4—amyotrophic lateral sclerosis	2.08e-05	0.000224	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PLB1—amyotrophic lateral sclerosis	2.08e-05	0.000223	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—VEGFA—amyotrophic lateral sclerosis	2.07e-05	0.000222	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—CHAT—amyotrophic lateral sclerosis	2.06e-05	0.000222	CbGpPWpGaD
Cisplatin—ABCC5—Disease—CASP9—amyotrophic lateral sclerosis	2.05e-05	0.00022	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	2.04e-05	0.000219	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—FIG4—amyotrophic lateral sclerosis	2e-05	0.000216	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	1.95e-05	0.00021	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.94e-05	0.000208	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	1.93e-05	0.000207	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—GSR—amyotrophic lateral sclerosis	1.92e-05	0.000206	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CHMP2B—amyotrophic lateral sclerosis	1.89e-05	0.000203	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—DAO—amyotrophic lateral sclerosis	1.88e-05	0.000203	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.88e-05	0.000202	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PLB1—amyotrophic lateral sclerosis	1.87e-05	0.000202	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PLB1—amyotrophic lateral sclerosis	1.85e-05	0.000199	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	1.85e-05	0.000199	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	1.85e-05	0.000199	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	1.83e-05	0.000197	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—DAO—amyotrophic lateral sclerosis	1.81e-05	0.000195	CbGpPWpGaD
Cisplatin—ABCC5—Disease—ERBB4—amyotrophic lateral sclerosis	1.75e-05	0.000189	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.75e-05	0.000188	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.74e-05	0.000188	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—GSR—amyotrophic lateral sclerosis	1.73e-05	0.000186	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	1.73e-05	0.000186	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	1.73e-05	0.000186	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—GSR—amyotrophic lateral sclerosis	1.71e-05	0.000184	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PLB1—amyotrophic lateral sclerosis	1.71e-05	0.000184	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.69e-05	0.000182	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	1.69e-05	0.000182	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.65e-05	0.000177	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	1.64e-05	0.000176	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	1.64e-05	0.000176	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.61e-05	0.000173	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.6e-05	0.000173	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—APOE—amyotrophic lateral sclerosis	1.59e-05	0.000171	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	1.58e-05	0.00017	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—CHAT—amyotrophic lateral sclerosis	1.57e-05	0.000169	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.57e-05	0.000169	CbGpPWpGaD
Cisplatin—XDH—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.57e-05	0.000168	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—TP53—amyotrophic lateral sclerosis	1.56e-05	0.000168	CbGpPWpGaD
Cisplatin—PTGS2—Disease—VCP—amyotrophic lateral sclerosis	1.52e-05	0.000164	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.51e-05	0.000163	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	1.5e-05	0.000162	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.5e-05	0.000162	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	1.48e-05	0.000159	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.47e-05	0.000158	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	1.46e-05	0.000157	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.44e-05	0.000155	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.43e-05	0.000154	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PLB1—amyotrophic lateral sclerosis	1.43e-05	0.000154	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—CHAT—amyotrophic lateral sclerosis	1.42e-05	0.000153	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—TP53—amyotrophic lateral sclerosis	1.42e-05	0.000153	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—CHAT—amyotrophic lateral sclerosis	1.4e-05	0.000151	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	1.39e-05	0.000149	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	1.38e-05	0.000149	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.38e-05	0.000148	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PLB1—amyotrophic lateral sclerosis	1.37e-05	0.000148	CbGpPWpGaD
Cisplatin—ABCC5—Disease—APOE—amyotrophic lateral sclerosis	1.35e-05	0.000146	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—APOE—amyotrophic lateral sclerosis	1.35e-05	0.000146	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	1.34e-05	0.000144	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—APOE—amyotrophic lateral sclerosis	1.32e-05	0.000142	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GSR—amyotrophic lateral sclerosis	1.32e-05	0.000142	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.3e-05	0.00014	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.29e-05	0.000139	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	1.28e-05	0.000137	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GSR—amyotrophic lateral sclerosis	1.27e-05	0.000136	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	1.25e-05	0.000134	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.2e-05	0.000129	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.2e-05	0.000129	CbGpPWpGaD
Cisplatin—XDH—Metabolism—APOE—amyotrophic lateral sclerosis	1.18e-05	0.000127	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	1.15e-05	0.000124	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—APOE—amyotrophic lateral sclerosis	1.13e-05	0.000122	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.11e-05	0.000119	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.09e-05	0.000117	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CST3—amyotrophic lateral sclerosis	1.09e-05	0.000117	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CHAT—amyotrophic lateral sclerosis	1.08e-05	0.000117	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	1.07e-05	0.000115	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CHAT—amyotrophic lateral sclerosis	1.04e-05	0.000112	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	1.02e-05	0.00011	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.02e-05	0.000109	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.01e-05	0.000109	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	9.88e-06	0.000106	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—APOE—amyotrophic lateral sclerosis	9.84e-06	0.000106	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	9.83e-06	0.000106	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	9.65e-06	0.000104	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	9.46e-06	0.000102	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	9.34e-06	0.000101	CbGpPWpGaD
Cisplatin—ABCC5—Disease—PTGS2—amyotrophic lateral sclerosis	9.28e-06	9.99e-05	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.28e-06	9.99e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	9.05e-06	9.74e-05	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.04e-06	9.73e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	8.73e-06	9.4e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.45e-06	9.1e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—APOE—amyotrophic lateral sclerosis	8.36e-06	9e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.11e-06	8.73e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	7.95e-06	8.56e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CASP9—amyotrophic lateral sclerosis	7.93e-06	8.54e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.77e-06	8.37e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.77e-06	8.36e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	7.67e-06	8.26e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.63e-06	8.21e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.55e-06	8.13e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	7.17e-06	7.72e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.01e-06	7.54e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.94e-06	7.47e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	6.84e-06	7.36e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—ERBB4—amyotrophic lateral sclerosis	6.79e-06	7.31e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.74e-06	7.26e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	6.54e-06	7.04e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—APOE—amyotrophic lateral sclerosis	6.39e-06	6.88e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.82e-06	6.26e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—APOE—amyotrophic lateral sclerosis	5.77e-06	6.21e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.73e-06	6.17e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—APOE—amyotrophic lateral sclerosis	5.71e-06	6.14e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.59e-06	6.02e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.35e-06	5.75e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—APOE—amyotrophic lateral sclerosis	5.25e-06	5.65e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.14e-06	5.53e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.48e-06	4.82e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—APOE—amyotrophic lateral sclerosis	4.4e-06	4.73e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.38e-06	4.71e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—APOE—amyotrophic lateral sclerosis	4.23e-06	4.55e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.12e-06	4.44e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.95e-06	4.25e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.91e-06	4.21e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.85e-06	4.15e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.79e-06	4.08e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.54e-06	3.81e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	3.12e-06	3.36e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	2.91e-06	3.14e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.9e-06	3.12e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.14e-06	2.3e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	2e-06	2.15e-05	CbGpPWpGaD
